Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Epivir-HBV (Lamivudine) Oral Solution
Company:  GlaxoSmithKline
Application No.:  21-003S2 & 21004S2
Approval Date: 8/16/01


Date created: November 26, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.